Overcoming leukemia heterogeneity by combining T cell engaging bispecific antibodies
Background Leukemia represents about 5% of all human cancers. Despite advances in therapeutics, a substantial number of patients succumb to the disease. Several subtypes of leukemia are inherently more resistant to treatment despite intensive chemotherapy or targeted therapy.Methods Here we describe...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2020-10-01
|
| Col·lecció: | Journal for ImmunoTherapy of Cancer |
| Accés en línia: | https://jitc.bmj.com/content/8/2/e001626.full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|